Impact of coronavirus (COVID-19) pandemic on physical activity levels in different sub-populations of Iranians: a national survey.

Publication date: Jan 24, 2025

During the COVID-19 pandemic, the level of physical activity (PA) has been reported to decrease worldwide. A sedentary lifestyle is widely recognized as a significant risk factor for various diseases, necessitating extensive big data analysis to uncover the diverse aspects linked to the COVID-19 pandemic. Therefore, the aim of this study was to investigate the impact of the COVID-19 pandemic on PA levels across diverse population subsets in Iran and to identify the barriers to PA during the fifth wave of COVID-19 outbreak. Data from 7810 individuals (50. 8% male, 54. 8% married, 69. 6% 18-49 years) were collected using a standardized questionnaire comprising demographic details, levels of high, moderate, and low PA, daily sedentary time, PA at home, and barriers to PA. The questionnaire was distributed online via social platforms such as Telegram, WhatsApp, and Instagram. The obtained data were analyzed using the Chi-Square goodness-of-fit test and the Chi-Square test at a significance level of α 

Open Access PDF

Concepts Keywords
Coronavirus Adolescent
Daily Adult
Instagram Corona virus
Iranians COVID-19
Pandemic Exercise
Exercise training
Female
Humans
Iran
Male
Middle Aged
Middle Eastern People
Pandemics
Quarantine
SARS-CoV-2
Sedentary Behavior
Sedentary behaviors
Sports participation
Surveys and Questionnaires
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease MESH sedentary lifestyle
disease MESH lifestyle
disease MESH infection
disease IDO history
drug DRUGBANK Coenzyme M
disease MESH non communicable diseases
disease MESH obesity
disease MESH cardiovascular disease
disease MESH cancer
disease MESH diabetes mellitus
pathway REACTOME Immune System
disease MESH chronic diseases
disease MESH influenza
disease MESH upper respiratory tract infection
drug DRUGBANK Aspartame
disease MESH Marital status
drug DRUGBANK Proline
disease MESH complications
disease IDO country
disease MESH education level
drug DRUGBANK Green tea leaf
disease MESH hypertension
disease MESH anxiety
drug DRUGBANK L-Leucine
disease MESH oxidative stress
disease MESH cardiovascular risk factors
disease IDO cell
disease MESH inflammation
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)